Published: Jun 25, 2026, 19:12 IST | Updated: Jun 25, 2026, 19:12 IST
India is shifting its healthcare strategy from scale-driven generic production to innovation-led growth. Experts say the country is well-positioned to play a larger role in shaping global healthcare after COVID-19. Investments in research, biotechnology, pharmaceuticals, and medical technology are gaining momentum.